Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19 Medical Dialogues Bureau3 April 2020 4:45 AM GMTIntas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19 Medical Dialogues Bureau24 March 2020 6:15 AM GMTDelhi: Through the recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services as apprised about the regul...
CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19 Medical Dialogues Bureau22 March 2020 6:45 AM GMTDelhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO) , Directorate General of Health Services has released the regulatory ...
CDSCO updates procedure for issuance of WHO GMP Medical Dialogues Bureau15 March 2020 7:15 AM GMTNew Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services, has laid...
WHO warns of global shortage of medical equipment, surgical masks, protective gowns, gloves to fight coronavirus Medical Dialogues Bureau5 March 2020 9:44 AM GMTWashington: The World Health Organization (WHO) on Tuesday warned of a global shortage and price gouging for protective equipment to fight the fast-spr...
